Here, we asked whether Shh protein levels or biological activity in spinal fluid was less in ALS patients than controls, and whether these measures could be correlated with ALS disease severity, disease progression, and with other CSF analytes of biological interest in ALS. This evidence concerns the gene SHH and amyotrophic lateral sclerosis.